Appropriate use of cancer comprehensive genome profiling assay using circulating tumor DNA

Comprehensive genomic profiling (CGP) is being increasingly used for the routine clinical management of solid cancers. In July 2018, the use of tumor tissue‐based CGP assays became available for all solid cancers under the universal health insurance system in Japan. Several restrictions presently ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Sunami, Kuniko, Bando, Hideaki, Yatabe, Yasushi, Naito, Yoichi, Takahashi, Hideaki, Tsuchihara, Katsuya, Toyooka, Shinichi, Mimori, Koshi, Kohsaka, Shinji, Uetake, Hiroyuki, Kinoshita, Ichiro, Komine, Keigo, Takeda, Masayuki, Hayashida, Tetsu, Tamura, Kenji, Nishio, Kazuto, Yamamoto, Noboru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409307/
https://www.ncbi.nlm.nih.gov/pubmed/34128569
http://dx.doi.org/10.1111/cas.15022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409307/
https://www.ncbi.nlm.nih.gov/pubmed/34128569
http://dx.doi.org/10.1111/cas.15022

Ejemplares similares